Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain protein, Y chromosome-like pseudogene (gene symbol often abbreviated as CDYL pseudogene, Ensembl: ENSG00000282697) represents a nonfunctional segment of DNA homologous to the functional Chromodomain Y like (CDYL) gene, classified as a pseudogene[1][2][4]. Pseudogenes are typically incapable of producing functional protein products but may share significant sequence similarity to protein-coding genes[2][4]. They generally lack biological function and are excluded as direct drug targets or therapeutic entities, but in exceptional cases may generate regulatory RNA transcripts[4][6]. As a pseudogene, it does not encode a functional chromodomain-containing protein and has no direct molecular function, known biological role, or disease association, nor is it known to interact with drugs or serve as a clinical biomarker. Pseudogenes like this may complicate genetic analysis but are not themselves functional targets[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain protein, Y chromosome-like pseudogene.